These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 8531071)

  • 1. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
    Tosaki A; Engelman DT; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Mg++ manipulation prevents the proarrhythmic activity of cromakalim in ischemic/reperfused diabetic hearts.
    Tosaki A; Das DK
    J Pharmacol Exp Ther; 1997 Jul; 282(1):309-17. PubMed ID: 9223569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts.
    Tosaki A; Engelman DT; Engelman RM; Das DK
    Cardiovasc Res; 1996 Apr; 31(4):526-36. PubMed ID: 8689644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
    Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
    Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A; Hellegouarch A
    J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.
    Sargent CA; Smith MA; Dzwonczyk S; Sleph PG; Grover GJ
    J Pharmacol Exp Ther; 1991 Oct; 259(1):97-103. PubMed ID: 1920138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
    Du Toit EF; Muller CA; McCarthy J; Opie LH
    J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects against hydrogen peroxide-induced toxicity by activators of the ATP-sensitive potassium channel in isolated rat hearts.
    Gan XT; Cook MA; Moffat MP; Karmazyn M
    J Mol Cell Cardiol; 1998 Jan; 30(1):33-41. PubMed ID: 9500862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts.
    Tosaki A; Cordis GA; Szerdahelyi P; Engelman RM; Das DK
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):365-73. PubMed ID: 7515978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts].
    Taki H; Masuda Y; Yoshizumi M; Kitagawa T; Katoh I
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):438-44. PubMed ID: 8478573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.
    Grover GJ; Dzwonczyk S; Sleph PG; Sargent CA
    J Pharmacol Exp Ther; 1993 May; 265(2):559-64. PubMed ID: 8496806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
    Ford WR; Lopaschuk GD; Schulz R; Clanachan AS
    Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proarrhythmic effects of pinacidil are partially mediated through enhancement of catecholamine release in isolated perfused guinea-pig hearts.
    D'Alonzo AJ; Zhu JL; Darbenzio RB; Dorso CR; Grover GJ
    J Mol Cell Cardiol; 1998 Feb; 30(2):415-23. PubMed ID: 9515018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Block of cardiac ATP-sensitive K(+) channels reduces hydroxyl radicals in the rat myocardium.
    Obata T; Yamanaka Y
    Arch Biochem Biophys; 2000 Jun; 378(2):195-200. PubMed ID: 10860536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
    Picard S; Rouet R; Duval D; Chesnay F; Gérard JL
    J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.